18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prevalence of cardiovascular risk factors in Spanish HIV-1-infected male inmates

      abstract
      1 , , 1 , 2 , 1 , 3 , 3
      Journal of the International AIDS Society
      BioMed Central
      Tenth International Congress on Drug Therapy in HIV Infection
      7-11 November 2010

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose of the study HIV-1-infected inmates have an increased prevalence of some particular comorbidities. However, the cardiovascular risk(CVR) of this population has rarely been evaluated. Methods Cross-sectional study carried out among 216 male HIV-1 patients in prison. Patients were stratified according to age(<34, 35-39, 40-44, 45-49, 50-54 and >55 years old, respectively)and their CVR was assessed by Framingham(FRAM) equation. The prevalence of some further risk factors was also evaluated: time on antiretroviral therapy, nadir CD4 count, maximum viral load(VL), time on undetectable VL, HCV-coinfection, and cocaine use. Results Patients median age was 41 years(36-46), their median CD4 count was 386(240- 549)cells, 68% had an undetectable(<50 c/mL)VL, median nadir CD4 count was 207(104-315)cells, and 48% of them had a nadir CD4 count <200 cells. HCV-coinfection prevalence was 94%, cocaine consumption prevalence was 93.1%, and 54.2% of them were intravenous cocaine users. The FRAM 10-years CVR score among subjects studied was 5.88%. Figure 1 and Table 1. Figure 1 CVR stratified by age group. Table 1 Cardiovascular risk factors prevalence stratified by age group. Age Smokers Diabetes Hypertension Tot Chol > 200 HDL Chol <39 <34 99,44% 0,00% 8,33% 13,89% 72,22% 35-39 100% 3,23% 8,07% 8,07% 43,55% 40-44 100% 3,60% 12,50% 23,20% 51,80% 45-49 100% 0,00% 4,65% 9,31% 60,00% 50-54 100% 26,67% 20% 13,34% 46,00% 55-60 100% 0,00% 75% 100% 0,00% Overall prevalence 99,07% 3,70% 10,60% 15,27% 53,24% P 0,455 0,029 0,023 0,001 0,029 Age(p<0.001), total cholesterol(p<0.001), HDL cholesterol(p = 0.029), diabetes mellitus(p = 0.029), hypertension(p = 0.023), and nadir CD4 <200 cells(p = 0.04) were significantly associated with an increased CVR. Smoking, chronic HCV-hepatitis, cocaine use, and the HIV-1 VL were not significantly associated with an increased CVR. There is a trend towards an increased prevalence of hypercholesterolemia and hypertension paralleling the aging. Conclusions Using the FRAM scores, the median CVR of developing a cardiac event at 10 years in a population of Spanish HIV-1-infected inmate males is 5.88%. Of them, 5.1% have a high CVR, and are evenly distributed among age groups. The smoking prevalence is significantly higher than in non-inmate HIV-1 infected individuals, and is so high that it does not allow CVR differences among age groups. HCV-coinfection, cocaine use, and parenteral cocaine consumption were not associated with an increased CVR in our population. On the other hand, a lower nadir CD4 count was associated with high rates of CVR, thus supporting an earlier initiation of ARV therapy in HIV-1 infected males in the prison environment.

          Related collections

          Author and article information

          Conference
          J Int AIDS Soc
          Journal of the International AIDS Society
          BioMed Central
          1758-2652
          2010
          8 November 2010
          : 13
          : Suppl 4
          : P67
          Affiliations
          [1 ]Centre Penitenciari Quatre Camins, La Roca del Valles (Barcelona), Spain
          [2 ]Centre Penitenciari Brians II, Barcelona, Spain
          [3 ]Hospital Universitari Germans Trias, Fundació Lluita contra la SIDA, Barcelona, Spain
          Article
          1758-2652-13-S4-P67
          10.1186/1758-2652-13-S4-P67
          3113072
          3e5426a0-fb65-48ef-9a73-6ec0933f949d
          Copyright ©2010 Golf et al; licensee BioMed Central Ltd.

          This is an open access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

          Tenth International Congress on Drug Therapy in HIV Infection
          Glasgow, UK
          7-11 November 2010
          History
          Categories
          Poster Presentation

          Infectious disease & Microbiology
          Infectious disease & Microbiology

          Comments

          Comment on this article